INVESTOR ALERT: Brower Piven Encourages Shareholders Who

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
43
INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Novan, Inc. (Nasdaq: NOVN) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

STEVENSON, Md., Nov. 30, 2017 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Middle District of North Carolina on behalf of a class who purchased Novan, Inc. (Nasdaq: NOVN ) (“Novan” or the “Company”) common stock pursuant to Novan’s September 26, 2016 initial public offering (“IPO”) and/or on the open market between September 26, 2016 and January 26, 2017 (the “Class Period”).  Investors who wish to become proactively involved in the litigation have until January 2, 2018 to seek appointment as lead plaintiff.

If you wish to choose counsel to represent you and the Class, you must apply to be appointed lead plaintiff and be selected by the Court.  The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the Class in the action.  The lead plaintiff will be selected from among applicants claiming the largest loss from investment in connection with the Company’s IPO and/or during the Class Period.  Members of the Class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff.  No class has yet been certified in the above action.

The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 and the Securities Act of 1933 by virtue of the defendants’ failure to disclose in connection with the IPO and during the Class Period that the Company’s two Phase 3 clinical trials for its lead product candidate SB204 were not identical.

According to the complaint, following a January 27, 2017 announcement of top-line results where the drug failed to beat a placebo in the other separate study, the value of Novan shares declined significantly.

If you have suffered a loss in excess of $100,000 from investment in Novan’s September 26, 2016 IPO and/or during the class period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/casesandinvestigations.html .  You may also request more information by contacting Brower Piven either by email at hoffman@browerpiven.com or by telephone at (410) 415-6616.  Brower Piven also encourages anyone with information regarding the Company’s conduct during the period in question to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s.  If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice.  You need take no action at this time to be a member of the class.

Charles J. Piven Brower Piven, A Professional Corporation 1925 Old Valley Road Stevenson, Maryland 21153 Telephone: 410-415-6616 hoffman@browerpiven.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celebree Gains Franchise Momentum: A New Frontier

Updated Category News Views 13

The Climb: Celebree Schools on the Rise Here's a nugget in the franchise world that's causing a stir: Celebree School is making moves up the Franchise Times Top 400. When we're talking about a hop, skip, and jump through 84 spots since 2023, you can't help but notice. It's the third year in a row they're climbing this ladder, and it's making ripples. Franchise Expansion...

Continue Reading
Fluence Energy Faces Major Lawsuit Amid $3B Loss

Updated Category News Views 11

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

Continue Reading
VetsinTech's AI Training Boosts Military Careers

Updated Category News Views 29

A New Spin on Engineering Careers Sometimes it feels like every corner I turn in this market maze, there’s something about AI. It’s not just chirping in the tech world anymore; it’s banging on the doors of sectors like engineering, aerospace, and manufacturing. And now, VetsinTech is tossing its hat into the AI ring with a fresh program aimed at blending military...

Continue Reading
Trial for Former OB/GYN Arthur Park Begins in Bakersfield

Updated Category News Views 3

A Somber Day for Justice in Bakersfield There’s a buzz in the air, thick with anticipation and grief, as a trial seven years in the making kicks off in Bakersfield. It’s a significant affair, marking a turning point in a saga that’s shadowed the region with untold grief and unresolved accountability. We’re talking about the trial of Arthur Park, a former OB/GYN,...

Continue Reading
Montesodi 2023: A Fresh Chapter in Chianti Excellence

Updated Category News Views 4

A Glass Filled with History and Nature's Whimsy When you pour a glass of Montesodi 2023, you’re not just tasting wine but a story—a saga that blends Tuscany’s rich vineyard history with last year's unpredictable weather. Marchesi Frescobaldi, a name that’s seen it all over its thousand years, has once again shown us how resilience and tradition can marry with...

Continue Reading
New American Funding Expands in Carolinas with Mullinix Move

Updated Category News Views 18

The Gathering of Mortgage Titans You don't just waltz into the mortgage world with a $2 billion track record and expect folks not to notice. Will Mullinix, a name that's become synonymous in the Carolinas with mortgage mastery, has decided to bring his influential Mullinix Mortgage Group under the banner of New American Funding. Talk about a power play. This bold strategy...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 2

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
Coventry's Jacobs Joins European Life Settlement Execs

Updated Category News Views 20

Neal Jacobs Steps Up in Life Settlements Coventry has added another feather to its cap with Neal Jacobs, their Senior Managing Director of Capital Markets, joining the Executive Committee of the European Life Settlement Association (ELSA). Elected at ELSA's Annual General Meeting on September 15, 2026, Jacobs brings a wealth of experience that promises to bolster the...

Continue Reading
Canada and Ukraine Fortify Defense with UGV Partnership

Updated Category News Views 2

New Defense Fronts: Canada and Ukraine Join Forces October 13, 2026, marks an important day in Ottawa's defense narrative with Dominion Dynamics and Ukraine's TENCORE kicking off a robust partnership. They're not just collaborating; they're plugging into each other's strengths to build TerMIT uncrewed ground vehicles (UGVs) on Canadian soil. These aren't gizmos you find...

Continue Reading
TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Updated Category News Views 16

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Continue Reading

Top 5 Most Recently Viewed Articles

Ensurge Micropower ASA's Innovative Capital Increase Through Loan Conversion

Updated Category News Views 385

Ensurge Micropower ASA's Share Capital Increase Explained Recently, at an important shareholder assembly, Ensurge Micropower ASA made significant strides in reinforcing its financial structure. This assembly led to the authorization for a capital increase through the conversion of a notable convertible loan valued at NOK 4,500,000. This initiative is pivotal as it...

Continue Reading
General Dynamics Achieves Revenue Growth Despite EPS Shortfall

Updated Category News Views 52

General Dynamics Reports Revenue Increase in Q3 General Dynamics (NYSE: GD) has announced its third-quarter results, showcasing impressive revenue growth despite not meeting earnings expectations. The aerospace and defense giant reported a year-over-year revenue increase of 10.4%, totaling $11.7 billion, which is slightly above the forecast set by analysts at $11.69...

Continue Reading
Belgium Stock Market Insights: BEL 20 Trends and Insights

Updated Category News Views 201

Belgium Stock Market Overview Belgium's stock market experienced a downturn as trading came to a close, reflecting a delicate balance within various industry sectors. The notable sectors that influenced market movements included Telecoms, Technology, and Industrials, which saw a dip as shares in these categories were impacted by broader market trends. BEL 20 Index...

Continue Reading
Water Street Partners Expands Pharmacy Solutions with Pillr Health

Updated Category News Views 189

Water Street Healthcare Partners Invests in Pillr Health Healthcare Firm to Invest in Company's Expanding Pharmacy Solutions Water Street Healthcare Partners, a renowned strategic healthcare investor, has recently announced a significant investment in Pillr Health, a key provider of software and technology-enabled services geared towards optimizing pharmacy operations for...

Continue Reading
BlackLine Showcases Growth Potential as Analysts Upgrade Stock

Updated Category News Views 119

Back in early 2024, BlackLine (NASDAQ: BL) got a boost when Morgan Stanley upgraded its rating from Equalweight to Overweight, with a new price target of $70.00—up from $60.00. Traders perked up as the firm saw this stock trading at over a 35% discount compared to peers. It was like they uncovered gold in the rubble, and desks were buzzing about that potential. Margin...

Continue Reading